Latest News:

ar de elenfr it

TIF

Home » Clinical Trials – Press Announcements

Clinical Trials – Press Announcements

Protagonist Therapeutics (PTGX) Announces FDA Granted Orphan Drug Designation for PTG-300 for Treatment of Beta-Thalassemia

Montco biopharm firm begins human studies of iron overload therapy

La Jolla Pharmaceutical Company Announces Initiation of Multicenter, Randomized, Phase 2 Clinical Study of LJPC‑401 in Patients with Hereditary Hemochromatosis